We send the latest information from SMC Laboratories.
Devonian Health Group announced the availability of additional molecular data from a preclinical study using a…
We are pleased to announce an upcoming webinar focused on the evaluation of immunotherapy in hepatocellular ca…
SMC Laboratories has introduced Resmetirom, a THR-β agonist, as a positive control in the CDAHFD model for non…
Featured in Frontiers in Immunology: A Preclinical Package to Maximize the Value of Your MASH Candidate…